STOCK MARKET BSE NSE

Phase II human trial of Oxford COVID-19 vaccine begins in Pune

If the results of the trial are successful, the vaccine will be available for general people in the next two-three months.

Published: 26th August 2020 04:11 PM  |   Last Updated: 27th August 2020 09:50 AM   |  A+A-

According to Dr Lalwani, in all, 25 candidates will given the vaccine in the next seven days.

According to Dr Lalwani, in all, 25 candidates will given the vaccine in the next seven days. (Photo | Shekhar Yadav, EPS)

Express News Service

MUMBAI: The phase-2 trials of the Oxford University vaccine for Coronavirus began in India on Wednesday with two persons being given the first shots in Pune. The second dose will be given to them after 28 days. The vaccine, developed in collaboration with AstraZeneca, is believed to be the most promising. It is in phase-3 trials in some countries.

Five Puneites had enrolled for the vaccine test. Three of them tested positive while two negatives in an antibody test. Therefore, only two — a 32-year-old male and a 48-year-old male — were chosen for the trial by the Serum Institute of India and Indian Council of Medical Research (ICMR). If the results of the trial are successful, the vaccine will be available for general people in the next two-three months.

Indian rules require a vaccine to be tested within the country. Pune’s Serum Institute of India, which has an agreement with AstraZeneca to produce and market the vaccine, has thus initiated these trials. The phase-2 trials will take place at two more locations — KEM Hospital in Mumbai and PGI, Chandigarh.

CLICK HERE FOR COVID-19 LIVE UPDATES

More hospitals would be involved in phase-3 trials, during which the vaccine’s efficacy to protect the volunteers from the disease in real-life situations, is assessed. In phase-3, the vaccine is tried on thousands of volunteers.

Since these tests are only being repeated in India, a total of 1,600 volunteers are likely to be administered the vaccine during the phase-2 and 3 trials. India currently has more than 32.43 lakh Covid-19 cases while the death figure is 67, 151. For the last 22 days, India has seen the highest number of daily cases of coronavirus in the world, WHO has reported.

In Pune, the vaccine’s first recipient is a health worker while the second is a working professional. One of them told doctors at Pune’s Bharati Vidyapeeth that he and his wife had also offered themselves for the vaccine for swine flu. The other volunteer said he came to know about the trial vaccine through social media and enrolled. 

ALSO WATCH:



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp